Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model

References

• Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–786.
   PubMed Web of Science ®Google Scholar
• Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol. 2009;36:155–169.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Eifel PJ. Biological predictors of cervical cancer response to radiation therapy. Semin Radiat Oncol. 2012;22:143–150.
   PubMed Web of Science ®Google Scholar
• Höckel M, Knoop C, Schlenger K, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 1993;26:45–50.
   PubMed Web of Science ®Google Scholar
• Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol. 1998;48:149–156.
   PubMed Web of Science ®Google Scholar
• Sundfør K, Lyng H, Tropé CG, et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol. 2000;54:101–107.
   PubMed Web of Science ®Google Scholar
• Barwick TD, Taylor A, Rockall A. Functional imaging to predict tumor response in locally advanced cervical cancer. Curr Oncol Rep. 2013;15:549–558.
   PubMed Web of Science ®Google Scholar
• Ellingsen C, Hompland T, Galappathi K, et al. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts. Radiother Oncol. 2014;110:335–341.
   PubMed Web of Science ®Google Scholar
• Lyng H, Vorren AO, Sundfør K, et al. Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy. Int J Cancer. 2001;96:182–190.
   PubMed Web of Science ®Google Scholar
• Cooper RA, Carrington BM, Loncaster JA, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol. 2000;57:53–55.
   PubMed Web of Science ®Google Scholar
• Lyng H, Vorren AO, Sundfør K, et al. Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging. J Magn Reson Imaging. 2001;14:750–756.
   PubMed Web of Science ®Google Scholar
• Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res. 1998;4:2305–2312.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Baba T, Baba Y, et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology. 2000;216:803–809.
   PubMed Web of Science ®Google Scholar
• Zahra MA, Hollingsworth KG, Sala E, et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8:63–74.
   PubMed Web of Science ®Google Scholar
• Yuh WTC, Mayr NA, Jarjoura D, et al. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol. 2009;44:343–350.
   PubMed Web of Science ®Google Scholar
• Semple SIK, Harry VN, Parkin DE, et al. A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2009;75:611–617.
   PubMed Web of Science ®Google Scholar
• Andersen EKF, Hole KH, Lund KV, et al. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol. 2013;107:117–122.
   PubMed Web of Science ®Google Scholar
• Mannelli L, Patterson AJ, Zahra M, et al. Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer. AJR Am J Roentgenol. 2010;195:524–527.
   PubMed Web of Science ®Google Scholar
• Lund KV, Simonsen TG, Hompland T, et al. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer. Radiother Oncol. 2015;115:379–385.
   PubMed Web of Science ®Google Scholar
• Lund KV, Simonsen TG, Kristensen GB, et al. Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer. Acta Oncol. 2017;56:675–681.
   PubMed Web of Science ®Google Scholar
• Sourbron SP, Buckley DL. Classic models for dynamic contrast-enhanced MRI. NMR Biomed. 2013;8:1004–1027.
   Web of Science ®Google Scholar
• Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91–101.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232.
   PubMed Web of Science ®Google Scholar
• Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:621–628.
   PubMed Web of Science ®Google Scholar
• Hoffman U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med. 1995;33:506–514.
   PubMed Web of Science ®Google Scholar
• Brix G, Bahner ML, Hoffmann U, et al. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT—initial experience. Radiology. 1999;210:269–276.
   PubMed Web of Science ®Google Scholar
• Dickie BR, Rose CJ, Kershaw LE, et al. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability. Br J Cancer. 2017;116:1436–1443.
   PubMed Web of Science ®Google Scholar
• Graff BA, Benjaminsen IC, Brurberg KG, et al. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. J Magn Reson Imaging. 2005;21:272–281.
   PubMed Web of Science ®Google Scholar
• Egeland TAM, Simonsen TG, Gaustad JV, et al. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images. Radiat Res. 2009;172:339–347.
   PubMed Web of Science ®Google Scholar
• Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res. 1997;57:4777–4786.
   PubMed Web of Science ®Google Scholar
• Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res. 1998;58:3598–3602.
   PubMed Web of Science ®Google Scholar
• Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54:759–767.
   PubMed Web of Science ®Google Scholar
• Halle C, Andersen E, Lando M, et al. Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. Cancer Res. 2012;72:5285–5295.
   PubMed Web of Science ®Google Scholar
• Tatum JL, Kelloff GJ, Gillies RJ, et al. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol. 2006;82:699–757.
   PubMed Web of Science ®Google Scholar
• Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol. 2006;24:3293–3298.
   PubMed Web of Science ®Google Scholar
• Pacheco-Torres J, López-Larrubia P, Ballesteros P, et al. Imaging tumor hypoxia by magnetic resonance methods. NMR Biomed. 2011;24:1–16.
   PubMed Web of Science ®Google Scholar